Ads
-
Related paper
- SGLT-2 inhibitors: the glucosuric antidiabetics
- Effects on Metabolic Parameters of Addition of SGLT‐2 Inhibitors on Patients with Type2 Diabetes Inadequately Controlled with DPP‐IV Inhibitors and Metformin
- A REVIEW ON NEW TARGET INSULYSINE (IDE) & ITS INHIBITORS AS ANTIDIABETICS AGENTS
- Antidepressant Activity of SGLT – 2 Inhibitors in Albinomice, an Experimental Study
- Role of SGLT-2 Inhibitors in Treatment of Patients with Type 2 Diabetes and NAFLD
- SGLT 2 INHIBITORS: NEWER PARADIGMS IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION
- EFFECT OF SODIUM–GLUCOSE CO-TRANSPORT-2 (SGLT-2) INHIBITORS ON INTRA ORAL WOUND HEALING IN ALBINO RATS, AN EXPERIMENTAL STUDY
- Diabetes and its Complications and SGLT-2 Inhibitors: A Novel Therapy for Type 2 Diabetes Mellitus
- Topoisomerase Inhibitors and Types of Them
- PROTEASE INHIBITORS: A REVIEW